EsoCap reports positive topline results from ACESO Phase II trial investigating ESO-101 in eosinophilic esophagitis

Dr. Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma

Heidelberg Pharma AG Announces Changes to the Executive Management Board

HeartBeat.bio: First Multi-Chamber Heart Organoids Unravel Human Heart Development and Disease

EVOMEDIS Announces Strategic Partnership with Medical University of Graz and COREMED Graz to Foster Wound Healing Innovation

Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cash Runway

Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference

First multi-chamber heart organoids unravel human heart development and disease

Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering